Frontiers in Drug Safety and Regulation is a peer-reviewed english-language open-access journal published by Frontiers Media S.A. in Switzerland, operating under an open-access model since 2021. The journal covers Therapeutics. Pharmacology.
Authors are required to pay an article processing charge to publish in Frontiers in Drug Safety and Regulation; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, Frontiers in Drug Safety and Regulation has published 104 articles. Articles are minted with DOIs through the prefix 10.3389. All submissions undergo plagiarism screening before peer review.
Keywords
medicine, pharmacogenomics, clinical pharmacology and therapeutics
At a glance
- Publisher
- Frontiers Media S.A.
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2021
- Review time
- 15 weeks
- DOI prefix
10.3389- Plagiarism check
- Yes
ISSN
- electronic
- 2674-0869
Frequently asked questions
Is Frontiers in Drug Safety and Regulation peer-reviewed?
Does Frontiers in Drug Safety and Regulation charge an article processing charge (APC)?
What subjects does Frontiers in Drug Safety and Regulation publish?
What languages does Frontiers in Drug Safety and Regulation accept?
What is the ISSN of Frontiers in Drug Safety and Regulation?
2674-0869 (electronic).